110 related articles for article (PubMed ID: 33866333)
21. New index to assess the extent of bone disease in patients with prostate cancer using SPECT/CT.
Ichikawa H; Shibutani T; Onoguchi M; Taniguchi Y
Ann Nucl Med; 2022 Nov; 36(11):941-950. PubMed ID: 36048347
[TBL] [Abstract][Full Text] [Related]
22. Analysis of regional bone scan index measurements for the survival of patients with prostate cancer.
Kalderstam J; Sadik M; Edenbrandt L; Ohlsson M
BMC Med Imaging; 2014 Jul; 14():24. PubMed ID: 25012268
[TBL] [Abstract][Full Text] [Related]
23. Prognostic significance of extent of disease in bone in patients with androgen-independent prostate cancer.
Sabbatini P; Larson SM; Kremer A; Zhang ZF; Sun M; Yeung H; Imbriaco M; Horak I; Conolly M; Ding C; Ouyang P; Kelly WK; Scher HI
J Clin Oncol; 1999 Mar; 17(3):948-57. PubMed ID: 10071289
[TBL] [Abstract][Full Text] [Related]
24. Prediction of survival benefit using an automated bone scan index in patients with castration-resistant prostate cancer.
Mitsui Y; Shiina H; Yamamoto Y; Haramoto M; Arichi N; Yasumoto H; Kitagaki H; Igawa M
BJU Int; 2012 Dec; 110(11 Pt B):E628-34. PubMed ID: 22788759
[TBL] [Abstract][Full Text] [Related]
25.
Lengana T; Lawal IO; Boshomane TG; Popoola GO; Mokoala KMG; Moshokoa E; Maes A; Mokgoro NP; Van de Wiele C; Vorster M; Sathekge MM
Clin Genitourin Cancer; 2018 Oct; 16(5):392-401. PubMed ID: 30120038
[TBL] [Abstract][Full Text] [Related]
26. A prospective study of bone tumor response assessment in metastatic breast cancer.
Hayashi N; Costelloe CM; Hamaoka T; Wei C; Niikura N; Theriault RL; Hortobagyi GN; Madewell JE; Ueno NT
Clin Breast Cancer; 2013 Feb; 13(1):24-30. PubMed ID: 23098575
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of bone metastasis burden as an imaging biomarker by quantitative single-photon emission computed tomography/computed tomography for assessing prostate cancer with bone metastasis: a phantom and clinical study.
Motegi K; Matsutomo N; Yamamoto T; Koizumi M
Radiol Phys Technol; 2020 Sep; 13(3):219-229. PubMed ID: 32535819
[TBL] [Abstract][Full Text] [Related]
28. Comparison of skeletal segmentation by deep learning-based and atlas-based segmentation in prostate cancer patients.
Motegi K; Miyaji N; Yamashita K; Koizumi M; Terauchi T
Ann Nucl Med; 2022 Sep; 36(9):834-841. PubMed ID: 35773557
[TBL] [Abstract][Full Text] [Related]
29. Fully automated analysis for bone scintigraphy with artificial neural network: usefulness of bone scan index (BSI) in breast cancer.
Inaki A; Nakajima K; Wakabayashi H; Mochizuki T; Kinuya S
Ann Nucl Med; 2019 Oct; 33(10):755-765. PubMed ID: 31317398
[TBL] [Abstract][Full Text] [Related]
30. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
[TBL] [Abstract][Full Text] [Related]
31. A Pilot Trial Evaluating Zoledronic Acid Induced Changes in [
Vaishampayan UN; Tehrani OS; Lawhorn-Crews JM; Heilbrun LK; Dobson K; Smith D; Dickow B; Shields AF
Mol Imaging Biol; 2017 Dec; 19(6):810-816. PubMed ID: 28289967
[TBL] [Abstract][Full Text] [Related]
32. Integration of Bone and Computed Tomography Scans to Assess Bone Metastasis in Metastatic Castration-Resistant Prostate Cancer.
Parker SJ; Pond GR; Agarwal N; Alex A; Heilbrun ME; Sonpavde G
Clin Genitourin Cancer; 2017 Feb; 15(1):53-59. PubMed ID: 27338517
[TBL] [Abstract][Full Text] [Related]
33. The CT flare response of metastatic bone disease in prostate cancer.
Messiou C; Cook G; Reid AH; Attard G; Dearnaley D; de Bono JS; de Souza NM
Acta Radiol; 2011 Jun; 52(5):557-61. PubMed ID: 21498309
[TBL] [Abstract][Full Text] [Related]
34. Fluorocholine PET/CT predicts skeletal progression, skeletal event and cancer specific survival in patients with biochemical relapse for prostate cancer.
Zattoni F; Agostini E; Cattaneo F; Maruzzo M; Basso U; Zattoni F; Evangelista L
Clin Imaging; 2017; 43():110-116. PubMed ID: 28278446
[TBL] [Abstract][Full Text] [Related]
35. Bone scan index on bone scintigraphy and radiation therapy for bone metastases from cancers other than prostate and breast cancers: A retrospective observational study.
Ishibashi N; Maebayashi T; Kimura Y; Okada M
J Cancer Res Ther; 2022; 18(6):1716-1721. PubMed ID: 36412434
[TBL] [Abstract][Full Text] [Related]
36. Bone scan index as metastatic bone disease quantifier and predictor of radium-223-dichloride biochemical response.
Roque V; Jessop M; Pereira L; Gape P; Dizdarevic S; Sousa E; Carolino E
Nucl Med Commun; 2019 Jun; 40(6):588-596. PubMed ID: 30908340
[TBL] [Abstract][Full Text] [Related]
37. Bone scintigraphy as a gatekeeper for the detection of bone metastases in patients with prostate cancer: comparison with Ga-68 PSMA PET/CT.
Caglar M; Tuncel M; Yildiz E; Karabulut E
Ann Nucl Med; 2020 Dec; 34(12):932-941. PubMed ID: 32975741
[TBL] [Abstract][Full Text] [Related]
38. Quantification of Bone Metastasis of Castration-resistant Prostate Cancer After Enzalutamide and Abiraterone Acetate Using Bone Scan Index on Bone Scintigraphy.
Kadomoto S; Yaegashi H; Nakashima K; Iijima M; Kawaguchi S; Nohara T; Shigehara K; Izumi K; Kadono Y; Nakajima K; Mizokami A
Anticancer Res; 2019 May; 39(5):2553-2559. PubMed ID: 31092452
[TBL] [Abstract][Full Text] [Related]
39.
Fosbøl MØ; Petersen PM; Kjaer A; Mortensen J
J Nucl Med; 2018 Apr; 59(4):596-602. PubMed ID: 28864632
[TBL] [Abstract][Full Text] [Related]
40. A Preanalytic Validation Study of Automated Bone Scan Index: Effect on Accuracy and Reproducibility Due to the Procedural Variabilities in Bone Scan Image Acquisition.
Anand A; Morris MJ; Kaboteh R; Reza M; Trägårdh E; Matsunaga N; Edenbrandt L; Bjartell A; Larson SM; Minarik D
J Nucl Med; 2016 Dec; 57(12):1865-1871. PubMed ID: 27445289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
